Pathways of sphingolipid metabolism provide a very rich network of bioactive molecules whose emerging functions suggest key roles in the regulation of cell function. In particular, published and preliminary results suggest the global hypothesis that pathways linked to ceramide formation play key roles in cytokine- and chemotherapy-induced cancer cell death whereas the sphingolipid sphingosine-l-phosphate (SIP) may emerge as a key and novel regulator of tumor neo-vascularization. This overall hypothesis will be approached through the activities of 3 distinct projects: Project 1 will address the specific hypothesis that the de novo synthesis of ceramide and sphingomyelin hydrolysis define two distinct pathways of ceramide formation which mediate synergistic tumor cell death through two distinct mechanisms. Project 2 will test the specific hypothesis that the ability to sensitize uninfected and/or resistant tumor cells (by addition of antisense molecules, chemotherapy, or agents that induce ceramide levels), would promote a more proapoptotic phenotype, and this would facilitate bystander activity and achieve greater tumor cell killing. Project 3 will test the hypothesis that sphingosine kinase and its product SIP regulate tumor angiogenesis, and inhibiting this pathway could inhibit tumor angiogenesis. These 3 projects will be supported by an Administrative Core and by a unique Lipidomics Core that will provide analytical and synthetic lipid chemistry. The results of these interactive studies would bring this last frontier of cellular biochemistry (sphingolipid metabolism) into cancer biology research, generating significant and unique insights into cancer cell death and tumor angiogenesis. The studies should also result in the identification of novel strategies for cancer therapeutics aimed at inducing cancer cell death and/or inhibition of tumor angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA097132-03
Application #
6908093
Study Section
Subcommittee G - Education (NCI)
Program Officer
Arya, Suresh
Project Start
2003-08-01
Project End
2008-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$1,071,260
Indirect Cost
Name
Medical University of South Carolina
Department
Biochemistry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Bai, Aiping; Bielawska, Alicja; Rahmaniyan, Mehrdad et al. (2018) Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites. Bioorg Med Chem 26:6067-6075
Newcomb, Benjamin; Rhein, Cosima; Mileva, Izolda et al. (2018) Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5. J Lipid Res 59:1219-1229
Espaillat, Mel Pilar; Snider, Ashley J; Qiu, Zhijuan et al. (2018) Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment. FASEB J 32:2339-2353
Hannun, Yusuf A; Obeid, Lina M (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175-191
Schwartz, Nicholas U; Linzer, Ryan W; Truman, Jean-Philip et al. (2018) Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. FASEB J 32:1716-1728
Moorthi, Sitapriya; Burns, Tara Ann; Yu, Gui-Qin et al. (2018) Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation. FASEB J 32:4270-4283
Morris, Thomas G; Borland, Samantha J; Clarke, Christopher J et al. (2018) Sphingosine 1-phosphate activation of ERM contributes to vascular calcification. J Lipid Res 59:69-78
Coant, Nicolas; García-Barros, Mónica; Zhang, Qifeng et al. (2018) AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells. Oncogene 37:3852-3863
Ren, Jihui; Snider, Justin; Airola, Michael V et al. (2018) Quantification of 3-ketodihydrosphingosine using HPLC-ESI-MS/MS to study SPT activity in yeast Saccharomyces cerevisiae. J Lipid Res 59:162-170
Shimizu, Yoshiko; Furuya, Hideki; Tamashiro, Paulette M et al. (2018) Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model. Carcinogenesis 39:47-55

Showing the most recent 10 out of 215 publications